Reactive Thrombocytosis in Non-aneurysmal Subarachnoid Hemorrhage

Abstract Background The role of reactive thrombocytosis in non-aneurysmal subarachnoid hemorrhage (NA-SAH) is largely unexplored to date. Therefore, the impact of a quantitative thrombocyte dynamic in patients with NA-SAH and its clinical relevance were analyzed in the present study. Methods In this retrospective analysis, 113 patients with nontraumatic and NA-SAH treated between 2003 and 2015 at our institution were included. World Federation of Neurosurgical Societies admission status, cerebral vasospasm, delayed infarction, hydrocephalus, need for ventriculoperitoneal (VP) shunt, and Fisher grade were analyzed for their association with reactive thrombocytosis. Results Reactive thrombocytosis was not associated with hydrocephalus (p ≥ 0.05), need for VP shunt implantation (p ≥ 0.05), cerebral vasospasm (p ≥ 0.05), or delayed cerebral ischemia (p ≥ 0.05). Conclusion Our study is the first to investigate the role of thrombocyte dynamics, reactive thrombocytosis, and the clinical course of NA-SAH patients. Our analysis showed no significant impact of thrombocyte count on NA-SAH sequelae.

[1]  V. Seifert,et al.  Continuous Acetylsalicylic Acid Treatment Does Not Influence Bleeding Pattern or Outcome of Aneurysmal Subarachnoid Hemorrhage: A Matched-Pair Analysis. , 2018, World neurosurgery.

[2]  R. Nizard,et al.  Platelet activation and aggregation after aneurysmal subarachnoid hemorrhage , 2018, BMC Neurology.

[3]  V. Seifert,et al.  Influence of ABO blood type on the outcome after non-aneurysmal subarachnoid hemorrhage , 2018, Acta Neurochirurgica.

[4]  R. Du,et al.  The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis. , 2017, Journal of neurosurgery.

[5]  L. Alberio.  Brauchen wir Antithrombotika bei Thrombozytose? Pro , 2016 .

[6]  C. Ogilvy,et al.  Predictors and Outcomes of Suspected Heparin-Induced Thrombocytopenia in Subarachnoid Hemorrhage Patients , 2014, Interventional Neurology.

[7]  E. Tesoro,et al.  Treatment Outcomes of Heparin-Induced Thrombocytopenia in Subarachnoid Hemorrhage Patients: A 4-Year, Retrospective Single-Center Review , 2012, Neurocritical Care.

[8]  Nainesh C. Patel,et al.  Thrombocytosis and coronary occlusion. , 2012, JACC. Cardiovascular interventions.

[9]  A. Algra,et al.  Association of Platelet and Leukocyte Counts with Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage , 2010, Cerebrovascular Diseases.

[10]  L. Edvinsson,et al.  Subarachnoid hemorrhage induces enhanced expression of thromboxane A2 receptors in rat cerebral arteries , 2010, Brain Research.

[11]  D. Powner,et al.  Thrombocytosis in the NICU , 2008, Neurocritical care.

[12]  C. Graffagnino,et al.  The Value of CT Angiography and Transcranial Doppler Sonography in Triaging Suspected Cerebral Vasospasm in SAH Prior to Endovascular Therapy , 2008, Neurocritical care.

[13]  W. M. van den Bergh,et al.  Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. , 2007, The Cochrane database of systematic reviews.

[14]  A. Brawanski,et al.  A study of possible correlation between subarachnoid haemorrhage related vasospasm and the post-bleed blood platelet count chart in a Caucasian population , 2007, Acta Neurochirurgica.

[15]  W. M. van den Bergh,et al.  Randomized Controlled Trial of Acetylsalicylic Acid in Aneurysmal Subarachnoid Hemorrhage: The MASH Study , 2006, Stroke.

[16]  Y. Hirashima,et al.  Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. , 2005, Journal of neurosurgery.

[17]  B. Carr,et al.  Thrombocytosis in intensive care. , 2001, British journal of anaesthesia.

[18]  M. Nijsten,et al.  Blunted rise in platelet count in critically ill patients is associated with worse outcome , 2000, Critical care medicine.

[19]  B. Lüderitz,et al.  Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. , 1998, European heart journal.

[20]  L. Case,et al.  Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. , 1994, The American journal of medicine.

[21]  J. Lilleyman,et al.  Secondary thrombocytosis. , 1993, Archives of Disease in Childhood.

[22]  J. Erikssen,et al.  Blood Platelet Count and Function Are Related to Total and Cardiovascular Death in Apparently Healthy Men , 1991, Circulation.

[23]  E. Tani,et al.  Effects of subarachnoid hemorrhage and a thromboxane A2 synthetase inhibitor on intracranial prostaglandins. , 1991, Surgical neurology.

[24]  M. Vitiritti,et al.  Thrombocytosis , 2010, BMC Geriatrics.